These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1775614)

  • 1. Long-term alprazolam use: abuse, dependence or treatment?
    Romach MK; Busto UE; Sobell LC; Sobell MB; Somer GR; Sellers EM
    Psychopharmacol Bull; 1991; 27(3):391-5. PubMed ID: 1775614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of chronic use of alprazolam and lorazepam.
    Romach M; Busto U; Somer G; Kaplan HL; Sellers E
    Am J Psychiatry; 1995 Aug; 152(8):1161-7. PubMed ID: 7625464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of long-term alprazolam users in the community.
    Romach MK; Somer GR; Sobell LC; Sobell MB; Kaplan HL; Sellers EM
    J Clin Psychopharmacol; 1992 Oct; 12(5):316-21. PubMed ID: 1479048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
    Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
    J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term stability of alcohol and other substance dependence diagnoses and habitual smoking: an evaluation after 5 years.
    Culverhouse R; Bucholz KK; Crowe RR; Hesselbrock V; Nurnberger JI; Porjesz B; Schuckit MA; Reich T; Bierut LJ
    Arch Gen Psychiatry; 2005 Jul; 62(7):753-60. PubMed ID: 15997016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alprazolam and benzodiazepine dependence.
    Sellers EM; Ciraulo DA; DuPont RL; Griffiths RR; Kosten TR; Romach MK; Woody GE
    J Clin Psychiatry; 1993 Oct; 54 Suppl():64-75; discussion 76-7. PubMed ID: 8262891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study.
    Feinstein A; Stergiopoulos V; Fine J; Lang AE
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(3):169-76. PubMed ID: 11513100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
    Lavie E; Fatséas M; Denis C; Auriacombe M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of alprazolam dependence and associated features among long-term alprazolam users from psychiatric outpatient clinics in Taiwan.
    Chen TT; Ko CH; Chen ST; Yen CN; Su PW; Hwang TJ; Lin JJ; Yen CF
    J Formos Med Assoc; 2015 Nov; 114(11):1097-104. PubMed ID: 24840273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine dependence of several years duration: clinical profile and therapeutic benefits.
    Tennant FS; Pumphrey EA
    NIDA Res Monogr; 1984; 55():211-6. PubMed ID: 6443381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam.
    Albeck JH
    J Clin Psychiatry; 1987 Oct; 48 Suppl():43-9. PubMed ID: 2889723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.